Superfluid Dx, Inc. is a cutting-edge biotechnology company based in San Diego, CA, dedicated to revolutionizing diagnostics for neurodegenerative diseases, with a current focus on Alzheimer's Disease. Their innovative cf-mRNA technology allows for early detection of Alzheimer's, personalized treatment guidance, and minimally invasive monitoring of disease progression over time.
By offering a non-invasive alternative to traditional diagnostic procedures like spinal taps and brain scans, Superfluid Dx aims to address urgent medical needs in Alzheimer's research and provide patients with more accurate and timely interventions. Their liquid biopsy approach holds promise for transforming the way neurodegenerative diseases are diagnosed and managed in clinical settings.
Generated from the website